Abstract
Conclusions
The plasma antitrypsin test does not show changes in association with early or minimal lesions of cancer.
2) The test may aid in excluding the diagnosis of advanced but non-terminal malignancy, or in the discovery of these lesions when they present themselves in obscure form.
3) Since antitrypsin values appear to be closely related to the growth of seminoma of the testis, it suggested that the test may have unique prognostic value in the study of this condition.
Get full access to this article
View all access options for this article.